Displaying 1 - 6 of 6
| Active Ingredient | CITALOPRAM |
| Therapeutic Class | SELECTIVE SEROTONIN REUPTAKE INHIBITORS |
| Indications | Major depression, obsessive-compulsive disorder, panic disorder. |
| Caution | As for fluoxetine. |
| Dose Range | Initial dose of 20mg/day as a single dose, increase as required after one week to a maximum of 40mg/day . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DESVENLAFAXINE |
| Therapeutic Class | SELECTIVE SEROTONIN REUPTAKE INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ESCITALOPRAM |
| Therapeutic Class | SELECTIVE SEROTONIN REUPTAKE INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FLUOXETINE |
| Therapeutic Class | SELECTIVE SEROTONIN REUPTAKE INHIBITORS |
| Indications | Depression, obsessive compulsive disorder, bulimia nervosa, premenstrual dysphoric disorder. |
| Caution | The main side effect is nausea; other side effects are hypotension, CNS symptoms (headache, anxiety, nervousness, insomnia), dry mouth, anorexia and visual disturbances; weight loss (but not weight ga More ... |
| Dose Range | Usual effective dose for depression, obsessive compulsive disorder and premenstrual dysphoric disorder is 20mg/day in the morning; however, doses up to 80mg/day have been used. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PAROXETINE |
| Therapeutic Class | SELECTIVE SEROTONIN REUPTAKE INHIBITORS |
| Indications | Major depression, obsessive-compulsive disorder, panic disorder. |
| Caution | As for fluoxetine. |
| Dose Range | Adult: 10-60mg daily. Maximum dose in the elderly 40mg daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | SERTRALINE |
| Therapeutic Class | SELECTIVE SEROTONIN REUPTAKE INHIBITORS |
| Indications |
Major depressive disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, premenstrual dysphoric disorder and social phobia. |
| Caution | Antidepressants increased the risk of suicidal thinking and behavior in children, adolescents, and young adults in short-term studies with major depressive disorder (MDD) and other psychiatric disorde More ... |
| Dose Range |
Adult: 50 mg daily increased, if necessary, in increments of 50 mg at intervals of at least a week to a maximum of 200 mg daily. Child: Obsessive-compulsive disorder: children 6-12 yr, 25mg/day, 13-17 yr, 50mg/day orally as a single dose in the morning or |
| Drug Interactions | |
| Pregnancy | Category C |
| Breast Feeding |